Capmatinib improves insulin sensitivity and inflammation in palmitate-treated C2C12 myocytes through the PPARδ/p38-dependent pathway-Reference-Cited by-同舟云学术

Capmatinib improves insulin sensitivity and inflammation in palmitate-treated C2C12 myocytes through the PPARδ/p38-dependent pathway

Published:2021-08 Issue: Volume:534 Page:111364
ISSN:0303-7207
Container-title:Molecular and Cellular Endocrinology
language:en
Short-container-title:Molecular and Cellular Endocrinology

Author:

Jung Tae Woo^ORCID,Lee Hyun Jung^ORCID,Pyun Do Hyeon,Kim Tae Jin,Bang Joon Seok,Song Jin-Ho^ORCID,Shin Yong Kyoo,Abd El-Aty A.M.^ORCID,Jeong Ji Hoon^ORCID

Funder

Ministry of Science and ICT, South Korea

National Research Foundation of Korea

Publisher

Elsevier BV

Subject

Endocrinology,Molecular Biology,Biochemistry

Reference40 articles.

1. Capmatinib attenuates lipogenesis in 3T3-L1 adipocytes through an adenosine monophosphate-activated protein kinase-dependent pathway;Ahn;Biochem. Biophys. Res. Commun.,2021

2. Are obesity-related metabolic risk factors modulated by the degree of insulin resistance in adolescents?;Bacha;Diabetes Care,2006

3. p38 MAPK-induced nuclear factor-kappaB activity is required for skeletal muscle differentiation: role of interleukin-6;Baeza-Raja;Mol. Biol. Cell,2004

4. PPAR delta: a dagger in the heart of the metabolic syndrome;Barish;J. Clin. Invest.,2006

5. Lipid induced overexpression of NF-kappaB in skeletal muscle cells is linked to insulin resistance;Barma;Biochim. Biophys. Acta,2009

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological activation of pyruvate dehydrogenase by dichloroacetate protects against obesity-induced muscle atrophy in vitro and in vivo;European Journal of Pharmacology;2024-09

2. Capmatinib suppresses LPS-induced interaction between HUVECs and THP-1 monocytes through suppression of inflammatory responses;Biomedical Journal;2023-04

3. Experimental Approaches to Diabetes Mellitus;The Eurasian Journal of Medicine;2023-01-18